IRADIMED CORPORATION
DE ˙ DB ˙ US46266A1097
76,50 € ↓ -1,50 (-1,92%)
2026-06-03
AKTIENPREIS
SecurityDE:46K / IRADIMED CORPORATION
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership4,389 shares
Latest Disclosed Value $ 422,485
Squarepoint Ops LLC ownership in 46K / IRADIMED CORPORATION

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 4,389 shares of IRADIMED CORPORATION (DE:46K) valued at $357,704 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on August 27, 2025 disclosing 0 shares of IRADIMED CORPORATION. The current value of the position is $335,758 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IRADIMED COM 46266A109 4,389 4,389 422 0.0005
2025-08-27 2025-03-31 13F/A-1 IRADIMED COM 46266A109 0 -100.00 0
2025-05-15 2025-03-31 13F IRADIMED COM 46266A109 0 -100.00 0
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 15,764 4,591 41.09 867 54.55 0.0009
2024-11-14 2024-09-30 13F IRADIMED COM 46266A109 11,173 -10,622 -48.74 562 -41.38 0.0009
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 21,795 9,343 75.03 958 74.95 0.0016
2024-05-15 2024-03-31 13F IRADIMED COM 46266A109 12,452 12,452 548 0.0009
2020-08-14 2020-06-30 13F IRADIMED COM 46266A109 0 -13,670 -100.00 0 -100.00
2020-05-15 2020-03-31 13F IRADIMED COM 46266A109 13,670 -14,634 -51.70 292 -55.89 0.0075
2020-02-14 2019-12-31 13F IRADIMED COM 46266A109 28,304 14,672 107.63 662 130.66 0.0039
2019-11-14 2019-09-30 13F IRADIMED COM 46266A109 13,632 13,632 287 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.